178 studies found for:    breast,cancer,prevention | Open Studies
Show Display Options
Rank Status Study
21 Recruiting Prevention Strategy for Pre-Menopausal Women at High Risk for Development of Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Placebo;   Drug: secoisolariciresinol
22 Recruiting Detection and Prevention of Anthracycline-Related Cardiac Toxicity With Concurrent Simvastatin
Conditions: Breast Cancer;   Stage I Breast Cancer;   Stage II Breast Cancer;   Stage III Breast Cancer
Interventions: Drug: Simvastatin;   Drug: Doxorubicin/cyclophosphamide
23 Unknown  Statins and Breast Cancer Biomarkers
Condition: Breast Cancer
Interventions: Drug: Atorvastatin;   Drug: Placebo
24 Recruiting Prophylactic Irradiation to the Contralateral Breast for BRCA Mutation Carriers Undergoing Treatment for Breast Cancer
Condition: Breast Cancer
Intervention: Radiation: Prophylactic radiation to the contralateral breast
25 Unknown  Study of 0.1% Uracil Ointment (1UO) Ointment for the Prevention of Hand-Foot Syndrome
Conditions: Palmar-Plantar Erythrodysesthesia;   Breast Cancer
Interventions: Drug: Ointment;   Drug: 0.1% Uracil Ointment
26 Recruiting Exercise to Prevent Aromatase Inhibitor Side Effects in Breast Cancer Patients
Conditions: Breast Cancer;   Sarcopenia
Interventions: Other: Structured Exercise;   Other: Usual Care
27 Recruiting My Lifestyle Intervention of Food and Exercise
Condition: Breast Cancer
Interventions: Behavioral: Tailored Lifestyle Intervention (TLI);   Behavioral: Commercial Weight Loss Program (CWLP)
28 Recruiting Incidence of Febrile Neutropenia
Condition: Chemotherapy-induced Febrile Neutropenia
Intervention:
29 Recruiting Ethnic Differences in the Impact of Breast Cancer on Employment Status, Financial Situation, and Quality of Life
Condition: Breast Cancer
Intervention: Behavioral: survey web-based or telephone interview
30 Recruiting Carvedilol for the Prevention of Anthracycline/Anti-HER2 Therapy Associated Cardiotoxicity Among Women With HER2-Positive Breast Cancer Using Myocardial Strain Imaging for Early Risk Stratification
Condition: Breast Cancer
Interventions: Drug: Carvedilol;   Other: placebo
31 Unknown  Pasireotide LAR Administration in Lymphocele Prevention After Axillary Node Dissection for Breast Cancer
Condition: Breast Cancer
Interventions: Drug: PASIREOTIDE;   Drug: PLACEBO
32 Recruiting Efficacy and Safety Study of NeuVax™ (Nelipepimut-S or E75) Vaccine to Prevent Breast Cancer Recurrence
Condition: HER2 Low to Intermediate Breast Cancer
Interventions: Biological: NeuVax™ vaccine;   Biological: Leukine® (sargramostim, GM-CSF) and water for injection
33 Unknown  Use of Organic Germanium or Placebo for the Prevention of Radiation Induced Fatigue
Conditions: Localized Breast Cancer;   Localized Prostate Cancer;   Patients Receiving External Beam Radiotherapy
Interventions: Dietary Supplement: Organic Germanium;   Dietary Supplement: Placebo
34 Recruiting Clinical, Genetic, Behavioral, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Breast/Ovarian Cancer
Conditions: Familial Ovarian Cancer;   Familial Breast Cancer;   BRCA1-associate Malignancies;   BRCA2-associated Malignancies
Intervention:
35 Recruiting Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-Positive Operable or Locally Advanced Breast Cancer
Conditions: Estrogen Receptor Positive;   HER2/Neu Positive;   Progesterone Receptor Positive;   Stage IB Breast Cancer;   Stage II Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer
Interventions: Drug: Docetaxel;   Drug: Carboplatin;   Biological: Trastuzumab;   Biological: Pertuzumab;   Drug: Goserelin Acetate;   Procedure: Therapeutic Conventional Surgery;   Radiation: Whole Breast Irradiation;   Other: Laboratory Biomarker Analysis;   Drug: Aromatase Inhibition Therapy;   Other: Quality-of-Life Assessment
36 Unknown  Study of Neoadjuvant Docetaxel and Cyclophosphamide in Locally Advanced or Node Positive Primary Breast Cancer With Companion Pharmacokinetic and Pharmacogenomic Analyses
Condition: Breast Cancer
Intervention: Drug: Neoadjuvant Docetaxel and Cyclophosphamide
37 Unknown  Education With or Without Exercise and Counseling in Preventing Lymphedema in Women With Stage I, Stage II, or Stage III Breast Cancer Who Are Undergoing Axillary Lymph Node Dissection
Conditions: Breast Cancer;   Lymphedema;   Perioperative/Postoperative Complications
Interventions: Behavioral: exercise intervention;   Other: educational intervention;   Procedure: assessment of therapy complications;   Procedure: complementary or alternative medicine procedure;   Procedure: management of therapy complications;   Procedure: quality-of-life assessment;   Procedure: therapeutic conventional surgery
38 Recruiting Lymphedema Prophylaxis in Breast Cancer Survivors Who Show Early Evidence of High-risk Status
Conditions: Lymphedema;   Breast Cancer
Intervention: Device: Flexitouch
39 Unknown  Study of the Effect of Glutamine Supplementation on Chemotherapy Induced Toxicities in Breast Cancer Patients
Condition: Breast Cancer
Interventions: Dietary Supplement: Glutamine;   Dietary Supplement: IV Glutamine
40 Recruiting Mucoadhesive Oral Wound Rinse in Preventing and Treating Stomatitis in Patients With ER- or PR-Positive Metastatic or Locally Recurrent Breast Cancer That Cannot be Removed by Surgery Receiving Everolimus
Conditions: Estrogen Receptor-positive Breast Cancer;   HER2-negative Breast Cancer;   Oral Complications;   Progesterone Receptor-positive Breast Cancer;   Recurrent Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer;   Stage IV Breast Cancer
Interventions: Drug: mucoadhesive oral wound rinse;   Other: laboratory biomarker analysis

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years